the recent concerns about calcium blockers decreasing survival
Maybe there really is something to all the recent concerns about calcium blockers decreasing survival...especially short-acting nifedipine and other calcium blockers in the dihydropyridine class.
At first many experts dismissed this as too preliminary.
Now a third study shows similar results...this time a decrease in survival in elderly patients taking short-acting nifedipine for hypertension.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote